Sartorius Stedim Biotech S.A. (ETR:56S1)

Germany flag Germany · Delayed Price · Currency is EUR
191.95
-0.05 (-0.03%)
Last updated: May 28, 2025
1.61%
Market Cap 18.75B
Revenue (ttm) 2.86B
Net Income (ttm) 204.30M
Shares Out n/a
EPS (ttm) 2.11
PE Ratio 91.80
Forward PE 41.43
Dividend 0.69 (0.36%)
Ex-Dividend Date Apr 2, 2025
Volume n/a
Average Volume 293
Open 191.95
Previous Close 192.00
Day's Range 191.95 - 191.95
52-Week Range 144.80 - 235.20
Beta n/a
RSI 47.26
Earnings Date Jul 22, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog... [Read more]

Industry Laboratory Analytical Instruments
Founded 1978
Employees 9,901
Stock Exchange Deutsche Börse Xetra
Ticker Symbol 56S1
Full Company Profile

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.

Financial Statements

News

There is no news available yet.